Robert J. Gould - Director at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
FULC on Nasdaq
All Insider Reports
All Insider Reports

Robert J. Gould - trading volume in the past year for Fulcrum Therapeutics, Inc.

Holdings reported by Robert J. Gould for Fulcrum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 454,864 $4,877,870 $10.72 02 Feb 2026 Direct
Stock Option (right to buy) 36,000 26 Jun 2025 Direct Common Stock

Transactions reported by Robert J. Gould for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.